Molecular and Cellular Characterization of Skull Base Tumors
Part of paid clinical trials in Pittsburgh, Pennsylvania.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT03759717
- Status
- Recruiting
Conditions
- Cellular Pathology
- Skull Base Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Observation — OTHERUnderstanding the biology of skull base tumors will teach the investigators about the genesis and/or mechanisms of treatment resistance. The investigators hope to ultimately identify new targets which will add to the armamentarium by which to treat these tumors.
Study Details
The purpose of the study is to analyze biological samples and genetic material for basic science research investigating the molecular and cellular characterization of skull base tumors.
Key Dates
- Start date
- Oct 3, 2018
- Status verified
- Sep 2025
- Primary completion
- Oct 3, 2028
- Completion
- Oct 3, 2028
Study Design
- Enrollment
- 4,000 participants (estimated)
Primary Outcome Measure
Patient overall survival will be measured and reported. [ Time Frame: Through study completion, an average of 10 years ]
Central Contacts
- Benita Valappil, MPH412-864-1744
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 |
Find similar trials in Pittsburgh, PA
By research site